Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study.
David M WilliamsAliya M RuslanRahim KhanDaneeshanan VijayasingamFizzah IqbalAyesha ShaikhJia LimRichard ChudleighRajesh PeterManeesh UdiawarStephen C BainJeffrey W StephensThinzar MinPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
Semaglutide provided clinically and statistically significant reductions in HbA1c, body weight, lipids and liver enzymes.